OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0910-AG38         View EO 12866 Meetings Received Date: 10/19/2015 
Title: "Tobacco Products" Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act 
Agency/Subagency: HHS / FDA   Stage: Final Rule 
Concluded Action: Consistent with Change  Concluded Date: 05/04/2016 
Legal Deadline: None  Economically Significant: Yes 
Publication Date: 05/10/2016  Unfunded Mandates: Private Sector 
Major: Yes  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: Yes  Small Entities Affected: Businesses 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: Yes Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected